Alembic Pharmaceuticals Limited is one of India’s oldest pharmaceutical companies, with a legacy dating back to 1907. The company develops, manufactures, and markets branded formulations, generic medicines, and active pharmaceutical ingredients across domestic and international markets. Alembic has established expertise in cardiology, anti-infectives, dermatology, diabetology, ophthalmology, oncology, and women’s healthcare while continuously expanding its specialty portfolio. The company operates modern manufacturing facilities approved by leading global regulatory agencies, supporting exports to the United States, Europe, and numerous emerging markets. Alembic maintains a strong commitment to research and development, focusing on complex generics, differentiated formulations, and product innovation. Its integrated manufacturing capabilities, quality-driven operations, and expanding global presence have strengthened its competitive position within the pharmaceutical industry. By emphasizing affordable healthcare, scientific excellence, and regulatory compliance, Alembic continues to serve patients and healthcare professionals across a broad range of therapeutic areas.
NSE: APLLTD | BSE: 533573
Vadodara, Gujarat, India
~14,000 employees
